HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Priya Luthra Selected Research

N- ((1R)- 6- chloro- 2,3,4,9- tetrahydro- 1H- carbazol- 1- yl)- 2- pyridinecarboxamide

10/2018Inhibiting pyrimidine biosynthesis impairs Ebola virus replication through depletion of nucleoside pools and activation of innate immune responses.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Priya Luthra Research Topics

Disease

5Infections
01/2019 - 11/2008
3Virus Diseases (Viral Diseases)
01/2017 - 02/2011
2Vesicular Stomatitis
10/2018 - 01/2018
1Neoplasms (Cancer)
01/2017
1Bites and Stings (Sting)
01/2017
1Human Influenza (Influenza)
04/2015

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
03/2017 - 08/2011
2DNA (Deoxyribonucleic Acid)IBA
03/2017 - 01/2017
2InterferonsIBA
01/2017 - 04/2015
1AntibodiesIBA
01/2019
1brequinarIBA
10/2018
1N- ((1R)- 6- chloro- 2,3,4,9- tetrahydro- 1H- carbazol- 1- yl)- 2- pyridinecarboxamideIBA
10/2018
1Dihydroorotate DehydrogenaseIBA
10/2018
1Antiviral Agents (Antivirals)IBA
01/2018
1cyclic guanosine monophosphate-adenosine monophosphateIBA
03/2017
1Peptide Hydrolases (Proteases)FDA Link
03/2017
1Mitochondrial DNA (mtDNA)IBA
03/2017
1CytokinesIBA
01/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2017
1Interferon Type IIBA
01/2017
1Interferon Regulatory Factor-7 (Interferon Regulatory Factor 7)IBA
04/2015
1Transcription Factors (Transcription Factor)IBA
04/2015
1Ebola virus nucleoprotein VP35IBA
07/2013
1Viral RNAIBA
08/2011
1RNA Helicases (RNA Helicase)IBA
02/2011
1IFIH1 Interferon-Induced HelicaseIBA
02/2011
1Interleukin-6 (Interleukin 6)IBA
11/2008